RxDoctor Payments Data

Stephen Gallagher, MD

Undersea and Hyperbaric Medicine · Lewiston, MENPI 1427076793

Payments from drug & device makers

$1,484in general payments, 2019–2025

Across 49 payments — averaging $30.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$846
  • Smith+Nephew$287
  • Medela LLC$77
  • Normatec Industries, LP$65
  • Mimedx Group, Inc.$47
  • Kerecis Limited$43
  • plus $120 from 6 others

What the payments were for

  • Food & beverage$1,484100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.26$846
Smith+Nephew9$287
Medela LLC2$77
Normatec Industries, LP3$65
Mimedx Group, Inc.2$47
Kerecis Limited1$43
Rochester Medical Corporation1$27
Hydrofera LLC1$25
Paratek Pharmaceuticals, Inc.1$24
Tactile Systems Technology Inc1$19
Advanced Oxygen Therapy Inc.1$13
Convatec Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few undersea and hyperbaric medicine providers in Maineto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$56,212
Medicare patients
206
Services billed
893

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pentoxifylline12$350
Doxycycline Hyclate17$228
Cephalexin14$185
Mupirocin15$170
Levofloxacin23$135
Clindamycin Hcl11$82
Prednisone12$58

Paid to pharmacies, not to this prescriber.

Other undersea and hyperbaric medicine in Lewiston

Where these figures come from

Is this you, or does something look wrong? →